论文部分内容阅读
目前已载入国家基本医疗目录的治疗心血管疾病的中成药近百种,因其疗效确切,毒副作用小,价格适中,被广大患者接受,但由于用药的盲目性、同类中成药或中西药联合应用等不合理现象不断增加,导致不良反应病例频频出现,不但可延误病情,对患者造成危害,严重者还将危及生命。
At present, nearly 100 kinds of proprietary Chinese medicines for the treatment of cardiovascular diseases have been included in the National Basic Medical Directory. Because of its definite curative effect, low toxic and side effects, and moderate price, it has been accepted by the majority of patients, but due to the blindness of medicines, similar proprietary Chinese medicines or Chinese and Western medicines. The unreasonable phenomena such as joint applications are increasing, resulting in frequent occurrence of adverse reactions. This can not only delay the illness but also cause harm to patients. Serious cases can also be life-threatening.